Serum Institute of India Ltd.
...
in 1966 with the aim of manufacturing life-saving immuno-biologicals, which were in shortage in the country and imported at high prices. Thereafter, several life-saving biologicals were manufactured at prices affordable to the common man and in abundance, with the result that the country was made self-sufficient for Tetanus Anti-toxin and Anti-snake Venom serum, followed by DTP (Diphtheria, Tetanus and Pertussis) group of Vaccines and then later on MMR (Measles, Mumps and Rubella) group of vaccines.The Philanthropic philosophy of the company still not only exists but has been proliferated to bring down the prices of newer vaccines such as Hepatitis-B vaccine, Rabies vaccine, Combination vaccine etc., so that not only Indian's, but the entire under-privileged children of the world, in more than 140 countries are protected from birth onwards.
Serum Institute of India have recently set up Serum Bio Pharma Park, India's first biotech Special Economic Zone (SEZ). The Park is adjoining Serum Institute's existing manufacturing unit and is a sector-specific SEZ meant for biotechnology and pharmaceutical products. The SEZ will allow Serum Institute of India to avail various tax benefits such as income tax, import duty on capital goods etc. This has encouraged a lot of foreign companies to partner with Serum Institute of India to avail and share these benefits. Area of Research:It is an endeavor to improve the health of the World’s Children by preventing diseases through immunizations. After developing the World’s first adsorbed liquid HDC rabies vaccine at a price that brings this ‘Gold Standard’ Rabies vaccine within the reach of the majority, we continue our relentless pursuit for conquering diseases and are in the process of developing and introducing several vaccines in the near future.Below are a list of products that Serum Institute intends to manufacture in the near future.
Vaccines:
Meningococcal A Conjugate Vaccine
Meningitis A, Y, C, W-135 Quadrivalent Vaccine
Bladder Cancer Vaccine
Pneumococcal Polysaccharide & Conjugate Vaccine
strong>Recombinant Products:
Recombinant Granulocyte Colony Stimulating Factor
Interferon Alpha
Recombinant Erythropoietin
The launch dates for the above products will be available shortly.
Products:
Bacterial Vaccines
Viral Vaccines
Recombinant and combination vaccine
Meningococcal A Conjugate vaccine Anti-Cancer products
Anti-Sera and Plasma Products
Hormonal products
Other pharma products
For the details of the products check out the this... http://www.seruminstitute.com/content/products/product_list.htm Technology:The production facilities of Serum Institute have the best in terms of equipment and human resources; essential to ensure high quality vaccines. The manufacturing facilities conform to WHO current Good Manufacturing Practice (cGMP) requirements and are approved by WHO, Geneva. The unique large bioreactors for DTP group of vaccines have a huge batch size to produce millions of doses.
The company also produces hundreds of millions of doses of the Measles, Mumps and Rubella group of vaccines annually. Serum Institute meets 100 % requirements for Measles vaccine of the Government of India and also the global requirements.
An interesting in-built mechanism of continuous improvement is by practicing the concept of Quality Circles. It empowers and encourages the employees at the grass-root level and at the same time brings about up gradation of quality of all fronts. The case studies of our Quality Circles have won many awards not only at State and national levels but also at the International Level. It goes without saying that Serum Institute's work ethic ensures that every safeguard is instituted, every norm of cGMP is scrupulously observed, and every procedure followed. Among the latest acquisitions is the state-of-the-art EDP system, which provides instant information on every aspect of production, from stocks, inventory, quantity of vaccines in the pipeline, Q.C. results of each batch, to sales, product dispatch and destinations.
State-of-the-art Recombinant Vaccine Manufacturing Facility:
Rabies Vaccine Manufacturing Facility:
Continuous Plasmapheresis Machine:This is a fully computerised blood separator designed for humans. Concern for the health and well-being also of animals has prompted Serum Institute scientists to modify the machine and adapt it for animals. Serum Institute is the first and only laboratory in the world where the Cobe Spectra is used for plasmapheresis of immunized equines.
Lyophilisation: Serum Institute has the largest computerized facility in India for Lyophilisation of parenterals; this complex process of freeze-drying is universally accepted as the best option for the preservation of biologicals. It increases the shelf-life and stability of the products.
Robotic Arm: Every advancement is quickly adopted like using Robots to handle our tissue culture - they are efficient with no room for error.
Finance & Stockshttp://www.moneycontrol.com/news/buzzingstocks/serum-institute-buys-10-lakh-shares-core-projects_503647.html
Press Release:
Friday, August 5, 2011 Serum Institute of India Ltd., Pune
Serum & Merck Announce Collaboration to Develop and Expand Global Access to Pneumococcal Conjugate Vaccine
Serum Institute of India Ltd. and Merck have entered into an agreement to develop and commercialize a pneumococcal conjugate vaccine (PCV) for use in the emerging and developing world countries of the world. more....
Monday, July 11, 2011 Press Information Bureau, Government of India
WHO lauds Serum Institute's efforts at BRICS meeting in China
WHO Director-General Dr. Margaret Chan singled out India's effort when she stated that when African countries wanted a meningococcal vaccine at a cost of not more than 50 cents, it was the Serum Institute of India which came forward and did the job. “All the major manufacturers of the world were approached by WHO but could not meet the cost criteria, which was critical for the African countries. The supply of this vaccine by India has saved hundreds and thousand of lives in low & middle income African countries, where a person contracting meningitis often means 4-5 months of a household's income” she said. more....
Tuesday, June 14, 2011 Times of India
City's Serum Institute plays vital role in saving lives
Bill Gates & British Prime Minister David Cameron praise Dr. Cyrus Poonawalla & Serum Institute for cutting vaccine prices. Serum offered GAVI the pentavalent vaccine at $1.75 per dose. The vaccine was purchased by GAVI a couple of years ago at more than $3 per dose. more....
Tuesday, June 14, 2011 Sakal Times
Serum's vaccine will be world's most affordable
Dr. Poonawalla makes far-reaching pledge to Global Alliance for Vaccines and Immunisation (GAVI) in London. Serum Institute has made a commitment to cut the price of its pentavalent vaccine by 60 % - the lowest possible cost in the world. more....
Tuesday, June 14, 2011 DNA
Pharma giants urged to lower vaccine prices
Serum Institute of India Ltd (SII), at an international meet in London, has appealed to big pharma companies and suppliers to follow the principle of ‘philanthropic pricing policy’ for the benefit of underprivileged children across the world.Poonawalla announced that SII has offered GAVI its pentavalent vaccine at $1.75, which was earlier purchased by GAVI at more than $3 per dose. “This is the most affordable vaccine offered by any manufacturer in the world,” Poonawalla said more....
Monday, June 13, 2011 DNA
Serum Institute lowers price of pentavalent vaccine
The Bill and Melinda Gates Foundation has welcomed the initiative of city-based pharmaceutical giant, Serum Institute of India (SII), to lower the price of its pentavalent vaccine for the developing world and for the United Nations Children’s Fund (Unicef).more....
Monday, June 13, 2011 Indian Express
Offer vaccines at lower prices: Poonawalla to pharma giants
Dr Cyrus Poonawalla, chief managing director of Serum Institute of India, on Monday urged big pharmaceutical firms to take their lead and offer vaccines at lower prices for saving lives. He was speaking at a pledging conference in London held by the Global Alliance for Vaccines and Immunisation (GAVI). British Prime Minister David Cameron and Bill Gates, co-founder of the Bill and Melinda Gates foundation. more....
Source: http://www.seruminstitute.com
Comment feed for this post
